Top Industry Leaders in the Americas Insomnia Market
Latest Americas Insomnia Companies Update
Eisai Co. Acquired the manufacturing rights and intellectual property for API to develop a new insomnia treatment, INVEGA SUSTENNA, currently in Phase III clinical trials.
Purdue Pharma L.P Faced ongoing legal challenges related to OxyContin and other opioid painkillers, impacting their sleep medication portfolio like Stadol NS.
Calm Leading meditation and sleep app platform, achieved unicorn status with a $4 billion valuation, highlighting the growing popularity of digital sleep solutions.
Headspace Another popular sleep and mindfulness app, partnered with several healthcare providers to integrate their platform into treatment plans.
List of Americas Insomnia Key Companies in the Market
- Eisai Co. (Japan)
- Pfizer Inc. (US)
- Merck & Co Inc (US)
- Sanofi (France)
- Takeda Pharmaceutical Company (Japan)
- Meda Consumer Healthcare Inc (US)
- Pernix Therapeutics (US)
- Purdue Pharma L.P. (US)
- Consumer Healthcare Inc. (Canada)
- Dainippon Sumitomo (Japan)
- ECR Pharmaceuticals (US)
- Flynn Pharma (UK)
- Johnson & Johnson (US)
- Astellas (UK)
- Biocodex S A (France)
- Neurim (Switzerland)
- SkyePharma (UK)
- Vanda Pharmaceuticals Inc. (US).